Adapsyn Bioscience

company

About

Adapsyn is developing a bioinformatics platform devoted to discovering previously unidentified natural product drug candidates.

  • 51 - 100

Details

Last Funding Type
Series Unknown
Industries
Bioinformatics,Biotechnology
Founded date
Jan 1, 2016
Number Of Employee
51 - 100
Operating Status
Active

Adapsyn Bioscience is a owner and operator of a biotechnology company intended to focus on the identification and characterization of microorganism-derived small molecules, to uncover chemical agents possessing novel biological activities relevant to the biotechnology and pharmaceutical sectors. The company's services is supported by cutting-edge bioinformatic software platforms and state of the art laboratory facilities, enabling researchers to drive the discovery of a diversified portfolio of drugs, thereby expediting the search for medicines that will better protect users from a wide spectrum of diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Adapsyn Bioscience has raised a total of — in funding over 2 rounds. Their latest funding was raised on Jan 11, 2018 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 11, 2018 Series Unknown 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Adapsyn Bioscience is funded by 1 investors. Pfizer R&D Innovate are the most recent investors.
Investor Name Lead Investor Funding Round
Pfizer R&D Innovate Series Unknown